Korea's Pulmonary Hypertension Crisis: Survival Rates Are Rising, But Patients Still Can't Access the Drugs That Could Save Them
South Korea's leading pulmonary hypertension society is pushing for faster drug approvals, national insurance coverage for breakthrough therapies, and the country's first-ever domestic clinical guidelines — as patient survival rates improve but still trail global benchmarks.
5h ago2,881 views